Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tarella, Corrado"'
Autor:
Tarella, Corrado, Zanni, M, DI NICOLA, M, Patti, C, Calvi, R, Pescarollo, A, Zoli, V, Fornari, A, Novero, D, Cabras, A, Stella, M, Comino, A, Remotti, D, Ponzoni, M, Caracciolo, D, Ladetto, Marco, Magni, M, Devizzi, L, Rosato, Rosalba, Boccadoro, Mario, Bregni, M, Corradini, P, Gallamini, A, Majolino, I, Mirto, S, Gianni, Am, GRUPPO ITALIANO TERAPIE INNOVATIVE NEI LINFOMI
Publikováno v:
Leukemia. 21:1802-1811
A prospective multicenter program was performed to evaluate the combination of rituximab and high-dose (hd) sequential chemotherapy delivered with multiple autologous peripheral blood progenitor cell (PBPC) support (R-HDS-maps regimen) in previously
Autor:
Vitolo, U, Bertini, M, Brusamolino, E, Cavallero, Gb, Comotti, B, Gallo, Eugenio, Ghio, R, Levis, A, Luxi, G, Meneghini, V, Novero, D, Orsucci, L, Rota Scalabrini, D, Tarella, Corrado, Todeschini, G, Viero, P, Barbui, T, Bernasconi, C, Perona, Gianni, Pileri, Alessandro, Resegotti, L.
Publikováno v:
Journal of Clinical Oncology. 10:219-227
PURPOSE The prognosis of advanced-stage diffuse large-cell lymphoma (DLCL) has improved with the use of the third-generation regimens such as methotrexate with leucovorin, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin (MACOP-B
Autor:
Cortelazzo, S, Rambaldi, A, Rossi, A, Oldani, E, Ghielmini, M, Benedetti, F, Tarella, Corrado, Zaglio, F, Vitolo, U, DI NICOLA, M, Pogliani, E, Cavalli, F, Gianni, Am, Barbui, T.
Publikováno v:
British journal of haematology. 114(2)
The aim of the present study was to retrospectively evaluate whether a high-dose sequential chemotherapy programme (HDS: cyclophosphamide, methotrexate, etoposide) administered prior to autologous transplantation could optimize the salvage of patient
Autor:
Guglielmi, C., Martelli, M., Federico, M., Zinzani, Pl, Vitolo, U., Bellesi, G., Santini, G., Tarella, Corrado, Zallio, F., Pregno, P., DI RENZO, N., Resegotti, L.
Our aim was to identify risk factors in adults with diffuse large cell lymphoma at first relapse.We studied 474 patients observed at 45 centers in Italy. Median time from diagnosis to relapse was 395 days, median age at relapse was 55 years and media
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3f09221180bc1bf530fc7573257ce2a6
http://hdl.handle.net/11573/256378
http://hdl.handle.net/11573/256378
Autor:
Alessio Bruscaggin, Francesco Passamonti, Thomas Tousseyn, Anna Guidetti, Luca Ceriani, Paolo Corradini, Francesco Piazza, Carlos Montalbán, Adalgisa Condoluci, Marco Bühler, Giorgio A. Vanini, Lodovico Terzi di Bergamo, M. Faderl, Urban Novak, Miguel A. Piris, Luisella Bonomini, Elena Sabattini, Liliana Devizzi, Govind Bhagat, Carlo Visco, Fabio Facchetti, Arianna Calcinotto, Francesca Guidetti, M. Ladetto, Umberto Vitolo, Francesco Bertoni, Armando López-Guillermo, Giuseppe Gritti, Thorsten Zenz, Valeria Spina, Renata Walewska, Marco Paulli, Julia T. Geyer, David Oscier, Catherine Thieblemont, Estella Matutes, Francesco Zaja, Elisa Lucchini, Alexandra Traverse-Glehen, Guido Ghilardi, Emanuele Zucca, Alberto J. Arribas, Renzo Boldorini, Marco Lucioni, Pier Luigi Zinzani, K. Pini, Alden A. Moccia, Stefano Pileri, Alexander Tzankov, Wu Wei, Angela Rita Elia, Maria Joao Baptista, Lydia Scarfò, Stefan Dirnhofer, Laurence de Leval, Sílvia Beà, Gabriela Bastidas, Alessandra Tucci, Giorgio Inghirami, Gianluca Gaidano, Gilles Salles, Felicitas Hitz, Enrico Derenzini, Gustavo Tapia, Ferdinando Bonfiglio, Alessandro Broccoli, Micol Giulia Cittone, Sascha Dietrich, Luca Arcaini, Paolo Ghia, Hossein Khiabanian, Michele Merli, Alessandro Rambaldi, Manuela Mollejo, Maria Cristina Pirosa, Deborah Piffaretti, Anastasios Stathis, Antonino Maiorana, Ricardo Koch, Juan F. García, Sergio Cogliatti, Gabriela Forestieri, Roberto Marasca, Stefano Pizzolitto, Elisa Santambrogio, Georg Stussi, Maurilio Ponzoni, Bernhard Gerber, Maria Gomes da Silva, Corrado Tarella, Luciano Cascione, Elias Campo, Luca Mazzucchelli, Davide Rossi, Véronique Meignin, Vincenzo Canzonieri, Franco Cavalli
Publikováno v:
Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Bonfiglio, Ferdinando; Bruscaggin, Alessio; Guidetti, Francesca; Terzi di Bergamo, Lodovico; Faderl, Martin Richard; Spina, Valeria; Condoluci, Adalgisa; Bonomini, Luisella; Forestieri, Gabriela; Koch, Ricardo; Piffaretti, Deborah; Pini, Katia; Pirosa, Maria C; Cittone, Micol Giulia; Arribas, Alberto; Lucioni, Marco; Ghilardi, Guido; Wu, Wei; Arcaini, Luca; Baptista, Maria Joao; ... (2022). Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma. Blood, 139(5), pp. 732-747. American Society of Hematology 10.1182/blood.2021012386
Blood, vol. 139, no. 5, pp. 732-747
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Bonfiglio, Ferdinando; Bruscaggin, Alessio; Guidetti, Francesca; Terzi di Bergamo, Lodovico; Faderl, Martin Richard; Spina, Valeria; Condoluci, Adalgisa; Bonomini, Luisella; Forestieri, Gabriela; Koch, Ricardo; Piffaretti, Deborah; Pini, Katia; Pirosa, Maria C; Cittone, Micol Giulia; Arribas, Alberto; Lucioni, Marco; Ghilardi, Guido; Wu, Wei; Arcaini, Luca; Baptista, Maria Joao; ... (2022). Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma. Blood, 139(5), pp. 732-747. American Society of Hematology 10.1182/blood.2021012386
Blood, vol. 139, no. 5, pp. 732-747
Splenic marginal zone B-cell lymphoma (SMZL) is a heterogeneous clinico-biological entity. The clinical course is variable, multiple genes are mutated with no unifying mechanism, and essential regulatory pathways and surrounding microenvironments are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84cc3c9dea90557598dbad050fac76c1
Autor:
Federico Fallanca, Roberto Sorasio, Umberto Ficola, Silvia Bolis, Guido Gini, Simonetta Viviani, Alessandra Romano, Piera Viero, Roberta Zanotti, Michele Cimminiello, Luca Guerra, Sara Oppi, Andrea Gallamini, Alessandro Rambaldi, Caterina Patti, Marco Picardi, Roberta Battistini, Livio Trentin, Andrea Rossi, Corrado Tarella, Corrado Schiavotto, Antonino Mulè, Maria Cantonetti, Chiara Pavoni, Stephane Chauvie
PURPOSE To investigate the role of consolidation radiotherapy (cRT) in advanced-stage Hodgkin lymphoma (HL) presenting at baseline with a large nodal mass (LNM) in complete metabolic response after doxorubicin, bleomycin, vinblastine, and dacarbazine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::455b594f83198e89f5d69cd3f44bc4d0
http://hdl.handle.net/11588/823892
http://hdl.handle.net/11588/823892
Autor:
Piera Viero, Simonetta Viviani, Giorgio La Nasa, A. Romano, D. Gottardi, Andrés J.M. Ferreri, Paolo Corradini, Livio Trentin, Alberto Biggi, Federico Fallanca, Maria Cantonetti, G. Gini, Atto Billio, Agostino Chiaravalloti, Giuseppe Prosperini, Davide Rapezzi, A. Mulè, Silvia Bolis, R. Zanotti, Marco Picardi, Chiara Pavoni, Guido Parvis, Corrado Tarella, Paolo Gavarotti, Alessandro Massimo Gianni, Maurizio Miglino, Fabrizio Bergesio, Alessandro Rambaldi, S. Chauvie, Abraham Avigdor, Roberta Battistini, Andrea Gallamini, Michele Gregianin, Andrea Rossi, Corrado Schiavotto, Umberto Ficola, Michele Cimminiello, C. Patti
Purpose To investigate the progression-free survival (PFS) of patients with advanced Hodgkin lymphoma (HL) after a risk-adapted treatment strategy that was based on a positive positron emission tomography scan performed after two doxorubicin, vinblas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d931ddc70a8cbce523dd881be6afda2b
https://hdl.handle.net/20.500.11769/542310
https://hdl.handle.net/20.500.11769/542310